Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.52 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9953334 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL9955627 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL538815 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL2566459 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL986357 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL8419701 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL2121084 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL687346 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL3899957 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL4132273 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2644185-B1 | THICK CLEANING COMPOSITION | SUZHOU ELECO CHEMICAL IND CO LTD (CN) | 2018-04-25 | — | — | EP | claimed |
| EP-2644185-A1 | THICK CLEANING COMPOSITION | Suzhou Yuansuji Chemical Industry Co., Ltd. (CN) | 2013-10-02 | — | — | EP | claimed |
| US-20130251648-A1 | THICK CLEANING COMPOSITION | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO., LTD. (CN) | 2013-09-26 | — | — | US | claimed |
| EP-4692226-A1 | SOLUTION, DISPERSANT, METHOD FOR PRODUCING VINYL COMPOUND POLYMER, AND METHOD FOR PRODUCING SOLUTION | Kuraray Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| EP-4674910-A1 | COMPOSITION COMPRISING VINYL ALCOHOL-BASED POLYMER, AND METHOD FOR SEPARATING VINYL ALCOHOL-BASED POLYMER | Kuraray Co., Ltd. (JP) | 2026-01-07 | — | — | EP | disclosed |
| WO-2024210066-A1 | SOLUTION, DISPERSANT, METHOD FOR PRODUCING VINYL COMPOUND POLYMER, AND METHOD FOR PRODUCING SOLUTION | 株式会社クラレ | 2024-10-10 | — | — | WO | disclosed |
| WO-2024181532-A1 | COMPOSITION COMPRISING VINYL ALCOHOL-BASED POLYMER, AND METHOD FOR SEPARATING VINYL ALCOHOL-BASED POLYMER | 株式会社クラレ | 2024-09-06 | — | — | WO | disclosed |
| CN-108635240-B | Dispersion liquid and hydrogel forming method | 日产化学工业株式会社 | 2021-09-14 | — | — | CN | disclosed |
| US-20200138695-A1 | COSMETIC COMPOSITION | ROHTO PHARMACEUTICAL CO., LTD. (JP) | 2020-05-07 | — | — | US | disclosed |
| EP-3616683-A1 | COSMETIC COMPOSITION | Rohto Pharmaceutical Co., Ltd. (JP) | 2020-03-04 | — | — | EP | disclosed |
| CN-110621295-A | Cosmetic composition | 日本乐敦制药株式会社 | 2019-12-27 | — | — | CN | disclosed |
| US-20130251648-A1 | THICK CLEANING COMPOSITION | SUZHOU YUANSUJI CHEMICAL INDUSTRY CO., LTD. (CN) | 2013-09-26 | — | — | US | disclosed |
| EP-1156033-B1 | PROCESS FOR PRODUCING ACIDIC N-(LONG-CHAIN ACYL)AMINO ACID | ASAHI CHEMICAL IND (JP) | 2011-12-07 | — | — | EP | disclosed |
| EP-1547998-B1 | NOVEL COMPOSITION CONTAINING ACYL GROUP | ASAHI KASEI CHEMICALS CORP (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-20090093388-A1 | NOVEL ACYL GROUP-CONTAINING COMPOSITION | ASAHI KASEI CHEMICALS CORPORATION | 2009-04-09 | — | — | US | disclosed |
| US-7488841-B2 | Composition containing acyl group | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2009-02-10 | — | — | US | disclosed |
| US-20050265951-A1 | Novel composition containing acyl group | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2005-12-01 | — | — | US | disclosed |
| EP-1547998-A1 | NOVEL COMPOSITION CONTAINING ACYL GROUP | Asahi Kasei Chemicals Corporation (JP) | 2005-06-29 | — | — | EP | disclosed |
| US-6569829-B1 | Removing impurities from a long chain N-acyl acidic amino acid such as N-lauroyl-L-glutamic acid containing an inorganic salt by solvent extraction using a solution of water and tert-butanol; use in cosmetics and detergents | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2003-05-27 | — | — | US | disclosed |
| EP-1156033-A1 | PROCESS FOR PRODUCING ACIDIC N-(LONG-CHAIN ACYL)AMINO ACID | Asahi Kasei Kabushiki Kaisha (JP) | 2001-11-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090093388-A1 | NOVEL ACYL GROUP-CONTAINING COMPOSITION | AADAC, ACADM, NAAA | GPR84 1405/4885FFAR1 805/4885ACE2 1637/4885 |
| US-20200138695-A1 | COSMETIC COMPOSITION | CUTA, LAGE3, SMURF1 | GPR84 770/4885FFAR1 454/4885ACE2 4273/4885 |
| US-20050265951-A1 | Novel composition containing acyl group | AADAC, ACADM, ADCK5 | GPR84 1478/4885FFAR1 704/4885ACE2 1534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.